MyFibroScan

2.8
47 reviews
10K+
Downloads
Content rating
Everyone
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image
Screenshot image

About this app

FibroScan® is the non-invasive solution for comprehensive management of liver health.

Fibroscan® provides unique and patented biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 2500 peer-reviewed publications and 60+ international guidelines.

myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way :

The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting Fibroscan® examination results.
Scores enhance Fibroscan® liver disease assessment with biological markers.
Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions.

- Agile™3+ is an aid to identify NAFLD patients with advanced fibrosis by combining VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins.

- Agile™4 is an aid to early identify NAFLD patients with cirrhosis by combining VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin.

- Fast™ is an aid to identify at risk NASH patients defined as NASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (NAFLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast™.
Updated on
Oct 28, 2024

Data safety

Safety starts with understanding how developers collect and share your data. Data privacy and security practices may vary based on your use, region, and age. The developer provided this information and may update it over time.
No data shared with third parties
Learn more about how developers declare sharing
This app may collect these data types
Personal info, App info and performance, and Device or other IDs
Data is encrypted in transit
You can request that data be deleted

Ratings and reviews

2.8
45 reviews
Chitranjan Suthar
July 16, 2021
A basic calculator is available on the web itself. Why not do that instead of telling this application my each and every detail for compulsory sign up. Wasted my 10 mins trying to set it up.
1 person found this review helpful
Did you find this helpful?
A Google user
June 28, 2019
freezes on LG phones with stock Oreo software. Works fine on non-LG phones or LG with custom PIE software
3 people found this review helpful
Did you find this helpful?
S Kenney
June 1, 2020
why is this cloud based ? why can I not get a score on my pt, it just says try back later. no computer browser program just smart phone.
2 people found this review helpful
Did you find this helpful?

What’s new

Update target Android version to run on Android 14

App support

About the developer
ECHOSENS
it-web@echosens.com
6 RUE FERRUS 75014 PARIS France
+33 1 87 67 50 82